Showing 1 - 2 results of 2 for search 'Anne Louise Kjølbye', query time: 0.03s Refine Results
  1. 1
    Selepressin, a novel selective vasopressin V1A agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients

    Selepressin, a novel selective vasopressin V1A agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients by James A. Russell, Jean-Louis Vincent, Anne Louise Kjølbye, Håkan Olsson, Allan Blemings, Herbert Spapen, Peder Carl, Pierre-Francois Laterre, Lars Grundemar

    Published 2017-08-01
    Get full text
    Article
  2. 2
    Study protocol of a randomised, double-blind, placebo-controlled, two-arm parallel-group, multi-centre phase 3 pivotal trial to investigate the efficacy and safety of recombinant human alkaline phosphatase for treatment of patients with sepsis-associated acute kidney injury

    Study protocol of a randomised, double-blind, placebo-controlled, two-arm parallel-group, multi-centre phase 3 pivotal trial to investigate the efficacy and safety of recombinant h... by Alexander Zarbock, Pierre-François Laterre, Peter Pickkers, Rinaldo Bellomo, Paul Young, Derek C Angus, Kent Doi, Michael Joannidis, Marlies Ostermann, Morten Bestle, Ravindra L Mehta, Patrick T Murray, John A Kellum, Jacques Arend, Christopher J Doig, Ville Pettilä, Bruno Francois, Erik van den Berg, Juliane Bernholz, Kristine Broglio, Jan Carlsen, Ricard Ferrer, Kathleen Liu, Sharon Richards, Anne Louise Kjølbye

    Published 2023-04-01
    Get full text
    Article

Search Tools: